bulgecin a has been researched along with Helicobacter Infections in 1 studies
*Helicobacter Infections: Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boneca, IG; Bonis, M; Guadagnini, S; Werts, C; Williams, A | 1 |
1 other study(ies) available for bulgecin a and Helicobacter Infections
| Article | Year |
|---|---|
The effect of bulgecin A on peptidoglycan metabolism and physiology of Helicobacter pylori.
Topics: Acetylglucosamine; Amoxicillin; Animals; Anti-Bacterial Agents; Cell Wall; Drug Synergism; Endopeptidases; Enzyme Inhibitors; Escherichia coli Proteins; Female; Glycoside Hydrolases; HEK293 Cells; Helicobacter Infections; Helicobacter pylori; Humans; Mice; Mice, Inbred C57BL; Models, Molecular; Penicillin-Binding Proteins; Peptidoglycan; Proline; Transfection | 2012 |